A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Amiodarone (Nexterone)

Amiodarone stabilizes heart rhythm in patients with irregular heartbeat.

First FDA approval2001-03-30
Generic availableYes · 15 mfrs
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one

$116.4M in CY2024 Part D spend4.8M claims · 1.6M beneficiaries · 329 plans surveyed

Lowest NADAC
$0.121/unit
20 NDCs benchmarked, lowest of all strengths.
Average NADAC
$0.122
Across all dosage forms in distribution.
Highest NADAC
$0.125
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema12 entries indexed · 4 visible
What is Amiodarone used for?

Amiodarone stabilizes heart rhythm in patients with irregular heartbeat.

Is there a generic for Amiodarone?

Yes. 27 ANDAs filed at FDA, 15 generic manufacturers currently shipping.

How much does my plan pay for Amiodarone?

Across 329 Part D plans, Amiodarone averages $0.122/unit (NADAC). Lowest available: $0.121/unit. Highest in distribution: $0.125/unit.

Is Amiodarone on the FDA shortage list?

No. Amiodarone is not currently on the FDA Drug Shortage Database.

8 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

Antiarrhythmic6 alternatives in D1
01
Dofetilide
Brand: Tikosyn
$0.182Lowest NADAC
8Generic mfrs
$96.7MCY24 Part D spend
Compare →
02
Dronedarone
Brand: Multaq
$13.19Lowest NADAC
1Generic mfrs
$626.9MCY24 Part D spend
Compare →
03
Flecainide
Antiarrhythmic
$0.112Lowest NADAC
7Generic mfrs
$77.9MCY24 Part D spend
Compare →
04
Lidocaine Hydrochloride
Brand: AKTEN
Lowest NADAC
25Generic mfrs
CY24 Part D spend
Compare →
05
Mexiletine
Antiarrhythmic
$0.254Lowest NADAC
8Generic mfrs
$14.2MCY24 Part D spend
Compare →
06
Procainamide
Antiarrhythmic
Lowest NADAC
5Generic mfrs
CY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (10 approvals on file) · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard (CY2024) · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.